Jake Murawski, PharmD, RPh

Experience

• 

  Giant Eagle, Inc.

  May 2015 - May 2021

  • Pharmacy Intern

    Jul 2019 - May 2021

  • Pharmacy Technician

    May 2015 - Jul 2019
• 

  UPMC Presbyterian Shadyside Hospital

  Apr 2020 - May 2023

  Pharmacy Intern

  • Recognized as the first intern in Pennsylvania history to administer a vaccine after giving the first COVID-19 vaccine at the UPMC Presbyterian Hospital• Helped establish the workflow and staff two COVID-19 vaccination sites • Prepared and administered COVID-19 vaccines to over 1,000 patients between 4 clinic sites• Awarded pharmacy employee of the month (March 2022) for educating floor nurses on chemotherapeutic products

• 

  Akebia Therapeutics

  May 2021 - Aug 2021

  Medical Outcomes Liaison Intern

  • Took part in the certification panel of two new hire MOLs, and assisted the MOL field training team with creating and approving content for field certification • Built a customer relationship management tool for the MOL team to preserve meeting appointments and heath care decision maker interactions • Prioritized and coordinated the MOL strategy toward approaching key external stakeholders following a competitor’s FDA Advisory Committee meeting • Developed and presented slide decks to multiple medical affairs matrix teams covering gaps in current trial evidence and new market entities to prepare for product launch Show less

• 

  Bayer

  Jul 2022 - Sept 2022

  Medical Communications/Medical Info Extern

  • Revised frequently asked questions, medical content letters, and Health Care Provider important safety information following Kerendia® label update • Co-led the creation of an interactive medical content letter to be utilized for adverse event inquiries • Formulated and distributed sales/MSL training on changes to the professional inquiry request form to notify field teams prior to launch• Refined call center phone tree and chatbot dialogue to streamline medical inquiries • Designed multiple upload checklists to simplify medical content submission to Bayer’s database Show less

• 

  Merck

  Sept 2022 - Nov 2022

  Global Labeling Extern

  • Worked with Global Labeling Leads to edit pembrolizumab PI for approval by Swissmedic, National Medical Products Administration (NMPA), and South African Health Products Regulatory Authority (SAHPRA)• Presented Keynote 522 Trial on Keytruda’s use in early triple negative breast cancer (TNBC) to inform Global Labeling team on future PI implications and regulatory strategies• Participated in global labeling strategy meetings, evaluating regulatory variations in labeling requirements and their implications on product usage across targeted international markets Show less

• 

  Massachusetts College of Pharmacy and Health Sciences

  Jul 2023 - now

  Adjunct Faculty
• 

  Sanofi

  Jul 2023 - now

  Medical Value & Outcomes